Platelet Transfusions: The Good, the Bad, and the Ugly
- PMID: 38621279
- DOI: 10.1213/ANE.0000000000006918
Platelet Transfusions: The Good, the Bad, and the Ugly
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Riley W, Cohn CS, Love K, McCullough J. Ensuring a reliable platelet supply in the United States. N Engl J Med. 2023;388:2017–2019.
-
- Burns CD, Bracey AW, Shander A, et al. Special Communication: Response to “Ensuring a Reliable Platelet Supply in the United States”. Anesth Analg. 2023;138:925–927.
-
- Beutler E. Platelet transfusions: the 20,000/microL trigger. Blood. 1993;81:1411–1413.
-
- Blumberg N, Heal JM, Liesveld JL, Phillips GL, Rowe JM. Platelet transfusion and survival in adults with acute leukemia. Leukemia. 2008;22:631–635.
-
- Baharoglu MI, Cordonnier C, Al-Shahi Salman R, et al.; PATCH Investigators. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet. 2016;387:2605–2613.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
